Last viewed: TRVN


Prices are updated after-hours



nasdaq:TRVN Trevena, Inc.

TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-28.5% 1m) (-46.1% 1y) (0.0% 2d) (0.3% 3d) (-4.8% 7d) (7.35% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 6,961,984

http://www.trevenainc.com
Sec Filling | Patents | 24 employees


(US) Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

urine   nervous system   injection  

Drugs
OLINVYK (OLICERIDINE)

add to watch list Paper trade email alert is off

Press-releases


Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
Published: 2024-04-01 (Crawled : 11:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: -11.52% H: 0.0% C: 0.0%

update results
CustomerInsights.AI Announces Strategic Advisory Board Members for 2024
Published: 2024-02-21 (Crawled : 17:00) - prnewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: -1.62% H: 1.63% C: 1.0%


Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise
Published: 2023-12-28 (Crawled : 19:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 4.23% C: 1.7%

million
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
Published: 2023-12-27 (Crawled : 14:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: 1.4% H: 2.1% C: -2.24%

million
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting
Published: 2023-12-04 (Crawled : 12:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: -4.22% H: 7.78% C: 6.91%

trv045 presentation meeting
Trevena Awarded OLINVYK Agreement with Premier, Inc.
Published: 2023-12-04 (Crawled : 12:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: -4.22% H: 7.78% C: 6.91%
PINC | $20.64 -0.29% -0.29% 1M twitter stocktwits trandingview |
Health Services
| | O: -0.29% H: 1.73% C: 1.59%

olinvyk agreement
Trevena Reports Third Quarter 2023 Results and Provides Business Update
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: -5.09% H: 5.52% C: 4.19%

business update results
Trevena to Release Third Quarter 2023 Financial Results on November 14, 2023
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: -2.18% H: 8.93% C: 5.36%

financial results
Trevena Reports Favorable TRV045 Topline Safety and Tolerability Data from Proof-of-Concept Studies
Published: 2023-10-16 (Crawled : 11:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 14.27% C: 7.14%

trv045 favorable topline
Trevena Announces Completion of Initial Analysis of OLINVYK Continuous Respiratory Monitoring Data from VOLITION Study and Presentation at American Society of Anesthesiologists Conference
Published: 2023-10-02 (Crawled : 11:00) - globenewswire.com
TRVN | $0.38 -3.31% -3.42% 470K twitter stocktwits trandingview |
Health Technology
| | O: -0.5% H: 7.15% C: 1.63%

conference respiratory presentation olinvyk study
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K twitter stocktwits trandingview |
Technology Services
| 00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M twitter stocktwits trandingview |
Finance
| 22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K twitter stocktwits trandingview |
Retail Trade
| 22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K twitter stocktwits trandingview |
Energy Minerals
| 21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M twitter stocktwits trandingview |
Health Technology
| 16:30
RMCF | $3.51 -3.7% -3.85% 3.8K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar